Jill Rollet is the Executive Editor at Endocrine Today. She specializes in medicine and healthcare, with a particular focus on medical specialties and healthcare technology. Jill's work has been featured in Healio.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Jill Rollet's coverage primarily focuses on healthcare, scientific developments, and health & wellbeing topics. She frequently cites data and provides expert commentary in her articles.
Given the nature of Jill's coverage, she is likely to be interested in pitches that offer access to credible experts who can provide insights into the latest scientific or medical research within women’s health, reproductive health, diabetes, menopause and related areas. Pitches should emphasize providing exclusive access to new data or studies as well as opportunities for expert commentary on relevant healthcare issues.
As there is no specific geographic focus mentioned for Jill Rollet's coverage area,pitches with international perspectives would likely be of interest given the global relevance of healthcare topics.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Richard Smith, Jill Rollet
HOUSTON — The novel drug atacicept was associated with significant reductions in proteinuria vs. placebo with comparable safety and no evidence of
By: Richard Smith, Jill Rollet
HOUSTON — Finerenone use for 6 months was safe and associated with a significant 25% decrease in albuminuria for adults with type 1 diabetes and
In the past decade, we have seen tremendous advances in the prevention, treatment and management of chronic kidney disease from modalities like hemodiafiltration to therapeutics that slow disease progression. We are also witnessing the integration of artificial intelligence and other technologies that are poised to transform how we deliver care.
By: Lucas Laboy, Erin T. Welsh, Jill Rollet
ASN Kidney Week, held in November, featured leading-edge science in kidney care, with evidence supporting new drugs to treat immunoglobulin A
By: Gabrielle M. Grasso, Richard Smith, Jill Rollet
Key takeaways: AI scribes, or ambient documentation technologies, listen to and transcribe patient-physician conversations.
By: Samir M. Parikh, Richard Smith, Jill Rollet
American Society of Nephrology members visited lawmakers in Washington D.C. on March 10 to advocate during their Hill Day for increasing visibility and research for kidney care.
By: Richard Smith, Jill Rollet, Kirk Campbell
Kidney disease is greatly underdiagnosed and undertreated in the United States, but recent initiatives aim to change that, according to Kirk Campbell, MD, president of the National Kidney Foundation.
By: Jill Rollet
NEW ORLEANS — Patients with decompensated heart failure and kidney disease may have care expectations and understanding of prognoses that are “misaligned” with outcomes, according to researchers.
NEW ORLEANS — Mentoring from other patients may contribute to faster recovery time for patients undergoing hemodialysis, according to study data presented at the National Kidney Foundation Spring Clinical Meetings. “Dialysis is a demanding treatment,” Tiffany Veinot, MLS, PhD, the Joan C. Durrance Collegiate Professor of Information at the University of Michigan School of Information, told
By: Lilia Cervantes, Lucas Laboy, Jill Rollet
Video Player is loading. Play Video Play Mute Current Time Duration Loaded Stream Type LIVE
